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SUMMARY This study was undertaken to better understand clinical char-
acteristics, environmental and physical events in Down syndrome (DS) and 
alopecia areata (AA). This cross-sectional study included 18 DS patients who 
were currently presenting or had presented AA. We evaluated gender, age, 
location and type of AA, presence of autoimmune disease or atopy, AA in 
first-degree relatives, and environmental, physical, and clinical intercurrenc-
es. The mean age of study subjects was 11.6 (SD ± 5.5) years and mean age 
at AA onset 7.2 (2.5 to 15.2) years. The duration of alopecia episodes varied, 
with a mean of 2.7 (0.1 to 18.7) years. Recurrence of AA was reported in 27.7% 
(5/18) of subjects, with a mean number of recurrences of 3.6. Localized type 
AA was seen in 83.4% of individuals, with the most frequent location on the 
scalp (100%). Seven of the individuals presented atopy. Fourteen individuals 
had undergone environmental and/or clinical intercurrences. In conclusion, 
the most frequent presentation of AA in DS is the non-recurrent, localized 
form on the scalp, with a varied period of duration. Changes in the individu-
als’ routine occurred in more than half of the study group. We suggest further 
studies of the psychology and immunogenetics in the etiopathology of AA 
in DS.
KeY woRDS: alopecia areata, Down syndrome
IntRoDUCtIon
Down syndrome (DS), trisomy 21, is the most fre-
quent chromosomal disease and a common cause 
of mental retardation, representing 10.0% to 30.0% 
of all cases with severe mental retardation (1). The 
prevalence of DS is approximately 1:770 births, with a 
slight preponderance in male gender (2). DS individu-
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als present an abnormal immune system, which leads 
to susceptibility to infections, with abnormal lympho-
cyte function, such as a decrease in immune-depen-
dent T-cell response (3,4) and IgG deficiency (5). Ana-
tomic evidence suggests that the immune defect in 
DS individuals is primarily due to disarrangement of 
the thymus as a consequence of lymphocyte deple-
tion, reduction of the cortex, loss of corticomedullary 
delimitation, and enlargement of Hassall’s corpuscles 
in the thymic medulla. Consequently, there is an ab-
normal thymic maturation, resulting in phenotypic 
and functional abnormalities in the circulating T-lym-
phocytes (4).
DS individuals present an increased incidence of 
autoimmune disorders such as thyroiditis, (6,7), moy-
amoya disease (8), diabetes mellitus type I (9), vitiligo 
(10), pernicious anemia (11), systemic lupus erythe-
matosus (12), chronic active autoimmune hepatitis 
(11) and alopecia areata (AA) (10,13). The most com-
mon autoimmune disease affects the thyroid gland 
and occurs more frequently after eight years of age 
(14). AA is described as asymptomatic, well-circum-
scribed, circular areas of hair loss ranging from 2 to 5 
cm in diameter; in extensive cases, coalescence of the 
lesions and/or involvement of other hairy surfaces 
is observed. (15,16). This entity is known as an auto-
immune disorder frequently associated with vitiligo 
(7,15,17), pernicious anemia, autoimmune adrenal in-
sufficiency and/or Hashimoto thyroiditis (7). AA may 
also be associated with atopy, emotional stress, sep-
tic focal points, as well as DS (15). The frequency of AA 
in DS varies from 1.3% to 11.0% (7,17-20). Wunderlich 
and Braun-Falco (19) were the first to describe the as-
sociation between AA and DS in 1965, although AA 
had already been described as a dermatologic find-
ing among patients with DS in 1954 (21). Carter and 
Jegasothy studied 214 institutionalized DS patients 
and observed 19 (8.9%) cases with AA (17).
The purpose of this study was to describe clinical 
characteristics and events possibly related to AA in 
DS individuals. 
SUBJeCtS AnD MethoDS
Subjects
Eighteen children and adolescents with DS were 
evaluated at the Medical Genetics Service of Mart-
agão Gesteira Pediatric Institute (IPPMG) – Federal 
University of Rio de Janeiro (UFRJ). Participants came 
from Martagão Gesteira Pediatric Institute, Fernandes 
Figueira Institute – FIOCRUZ and Gafreé-Guinle Hos-
pital – UNIRIO (convenience sampling). All individuals 
were diagnosed by cytogenetic analysis (G-banded 
karyotype, 550 bands) and presented a documented 
medical history of AA or presented alopecia at the time 
of consultation at the Medical Genetics Services. AA 
was considered to be hair loss leading to a ‘flaw’ on any 
hairy body surface. The clinical research protocol was 
approved by the Ethical Research Committee (IRB) of 
the IPPMG. The patients that participated in this study 
were all included in the database and platform that we 
have been developing named DataGenno (22).
Methods
A cross-sectional study was performed on a con-
venience sample of children and adolescents with 
DS. The following variables were studied: gender; 
age; location of alopecia; type of hair loss; presence 
of vitiligo, autoimmune disease or a suggestive his-
tory of atopy; history of AA in first-degree relatives; 
and environmental, physical, and clinical intercur-
rences. Data were collected from the individuals’ files 
and through interviews with parents and guardians 
then tabulated.
Statistical analysis
A descriptive analysis was performed and data 
were presented as percentage, mean, median and 
standard deviation.
ReSUltS
Sample characteristics
Eighteen children and adolescents with DS (11 
boys and 7 girls), mean age 11.6 years (SD ± 5.5; lim-
its: 3.8 to 21.7 years; median = 10.1 years) and current 
or previous history of AA were included in this study. 
In the total of 18 individuals studied, the mean age at 
AA onset was 7.2 years (limits: 2.5 to 15.2 years), me-
dian 7.7 years. The mean interval between the ages of 
the first alopecia episode and the time of the study 
was 4.3 years (limits: 0.1 to 12.8 years). Seven (38.9%) 
patients presented a positive clinical history of atopy; 
three individuals presented asthma; while two indi-
viduals presented with rhinitis and two with asthma 
and rhinitis. We did not find any individual with viti-
ligo and/or autoimmune disease. There was no pres-
ence of AA observed among first-degree relatives.
Characteristics of alopecia episodes
The duration of alopecia episodes varied greatly. 
The mean duration was 2.7 years (limits: 0.1 to 18.7 
years), median 1 year in individuals presenting only 
one episode (13/18). In the individuals who had more 
than one episode (5/18), the shorter-lasting episode 
was 0.4 years and the longer-lasting episode 2.4 years. 
In eight (41.1%) individuals, the clinical picture of AA 
persisted from the first episode, and in two of them, 
different body areas were affected, with periods of re-
mission in one of the areas.
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Recurrence of AA was reported in five (27.7%) in-
dividuals and the mean number of recurrences per 
individual was 3.6. Duration of the intervals between 
recurrences was obtained for only two of the subjects 
(2/5): 1.1 and 3.3 years. At the time of the study, 13 
individuals presented alopecia (four recurrent cases 
and nine non-recurrent cases). In all five recurrent 
cases, alopecia was observed in the same area that 
was originally affected.
A localized type of hair loss was seen in 83.4% 
of patients, and the most frequent location was the 
scalp (18/18; 100%). Two individuals presented com-
bined hair loss. In one case, the affected areas were 
the scalp, limbs, axilla, genitalia and face; in the sec-
ond case, the scalp and genitalia. There were no cases 
of total hair loss of the scalp.
environmental and clinical intercurrences
Fourteen (77.8%) individuals presented environ-
mental and/or clinical intercurrences, as follows: en-
vironmental (8/14), environmental and clinical (4/14), 
and clinical only (2/14). The most frequent environ-
mental intercurrences were change of school and 
teacher, followed by death of loved ones and paren-
tal separation.
Of the 18 participants, 36.6% (3/18) presented 
intercurrent illnesses (outpatient treatments of infec-
tions of the upper and lower respiratory tract and al-
lergic manifestations) during the study period, which 
were taken in consideration (before, during, and after 
alopecia) (Table 1). 
Change of school and/or teacher 
Seventeen individuals attended school; 10 of 
them underwent changes related to their school 
and/or teacher (10/17; 58.9%). Six subjects moved 
to different schools (6/17; 35.3%); in four individuals, 
the alopecia episodes preceded the school change; 
in one individual, the change occurred during an epi-
sode and one individual changed school twice: the 
first took place before the episode of alopecia and the 
other took place during an episode (Table 1). There 
was a change of teachers at the school in 41.2% of 
cases (7/17); in two cases, the teacher change preced-
ed the alopecia episode, in 2 other cases the teacher 
change occurred during the episode, in one case the 
change occurred after the episode of alopecia, and in 
two cases there were two teacher changes, one be-
fore an episode of alopecia and another change dur-
ing the same episode of alopecia (Table 1). None of 
the individuals held jobs. 
Change of residence
One of the individuals changed the place of resi-
dence during an episode of alopecia (Table 1).
table 1. Distribution of environmental, physical and clinical intercurrences in Down syndrome individuals 
with alopecia areata
I Age (yrs) Gender School 
change
teacher  
change
Change of 
residence
Ill family 
member
Death Separation Puberty Illness
01 3.7 M NA NA N N N N N N
02 3.7 F S1 S2 N N S2 ** S1 N N
03 6.0 F N N N N N N N N
04 6.4 F N N N N N S1 N N
05 8.2 M N S1 + S2 N N N N N N
06 8.6 M N S1 N N N N N S6
07 10.0 M N S1 N N N N N N
08 10.0 M N N N N N N N S6
09 10.0 F N N N N N N N N
10 10.2 M S1 N N N S3 * N N S6
11 10.5 F S2 N S2 N N N N N
12 11.1 F S1 S2 N N N N S2 N
13 15.6 M N N N N N N N N
14 15.9 M N N N S3 S3 * N N N
15 17.5 F N N N N N N S5 N
16 19.6 M S1 N N N N N N N
17 20.3 M S1 + S2 S1 + S2 N S3 N S2 S3 N
18 21.7 M N S3 N N S2 S2 N N
I = individual; yrs = years of age; M = male; F = female; N = no; NA = does not attend school; S1 = before alopecia; S2 = during 
alopecia; S3 = after alopecia; S4 = before and during alopecia; S5 = during and after alopecia; S6 = before, during, and after 
alopecia; * = grandmother; ** = grandparents. 
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Family problems
Family problems occurred in six of the study indi-
viduals (6/18; 33.4%), the most frequent being death of 
a family member (2/6), parental separation (2/6), and 
parental separation along with death of a close family 
member (2/6). In cases of deceased family members, 
three cases were death of grandparents and one was 
death of an aunt. The deaths occurred equally during 
(2/4) and after (2/4) the episode of alopecia. In two 
cases, parental separation took place prior to the alo-
pecia episode and in another two cases during the 
episode (Table 1). None of the individuals witnessed 
a conflict situation such as physical or verbal aggres-
sion. Two individuals had close family members who 
became ill during an episode of alopecia. 
Puberty
Two individuals entered puberty during an epi-
sode of alopecia and one after AA (Table 1).
DISCUSSIon
To our knowledge, this is the first study that de-
scribes the characteristics of AA, environmental and 
physical events in DS individuals. Due to its higher 
frequency in individuals with DS (7,17,19,20), AA is an 
entity that pediatricians, geneticists, and dermatolo-
gists should be aware of. This study presents limita-
tions related to parents’ memory (memory vice) and 
to convenience sampling. However, the results point 
to some important topics, which will be useful in the 
follow-up of these individuals.
The frequency of AA in DS has been reported by 
some authors, and it ranges from 1.3% to 11.0% (7,17-
20). The variation observed probably occurred due to 
the different patient samples and the assessments 
performed by the authors. Wunderlich and Braun-
Falco (19) predominantly studied children up to 8 
years of age and this factor may have been a deter-
minant for the lowest frequency observed (1.3%); Du 
Vivier and Munro (7) studied only the cephalic corpo-
real segment of alopecia and reported a frequency of 
6.0%. Carter and Jegasothy (17) report on a frequency 
of 8.9%, although they studied a smaller number of 
patients (214 patients versus 1000 patients evaluated 
in each of the previous studies), suggesting that al-
opecia is more frequent in individuals that have DS 
with greater cognitive limitations, as the patients in 
this study were institutionalized. Finally, Daneshpa-
zhooh et al. (20) report a frequency of 11.0% among 
100 DS patients. At the Medical Genetics Service of 
the IPPMG – UFRJ, the frequency was 4.1%, within the 
range of variation described in the literature.
Although the literature reports AA to be more 
frequent in females (17,23), the sample in this study 
was predominantly male (61.2%). Schepis et al. (24) 
also report a higher proportion of male than female 
individuals with AA and DS (12 male and one female). 
In relation to the total cases registered at the IPPMG 
with and without AA (15/352), the more frequent oc-
currence of AA in male individuals was not significant 
(χ2=3.39; P>0.05; DF=1).
There is no clear definition of age at AA onset, how-
ever, in a study of 736 patients carried out by Muller and 
Winkelmann (23), AA was more commonly observed in 
younger age groups (<16 years). The duration of the 
episodes varied, as did the intervals between the epi-
sodes. In the literature, we did not find a description 
of the duration of hair loss or the intervals between 
two episodes of AA. Muller and Winkelmann (23) dem-
onstrated that after hair loss there was a tendency to-
wards new hair growth, usually within a few months, 
and Rietschel (25) suggests that this type of alopecia 
tends to occur within a period of less than one year. 
Paradoxically, in the cases where only one episode was 
described, we found similar percentiles in relation to 
the duration of episodes when classified as less than 
one year and greater than or equal to one year. We ac-
knowledge that long periods of hair loss may in fact 
signify the presence of subsequent episodes of alo-
pecia that occurred after recovery from the initial epi-
sode, a frequent finding in many cases (23).
The recurrence of AA was observed in 5 (27.7%) 
cases. Muller and Winkelmann (23) found recurrence 
among adults and children without DS in 22.0% of 
cases. We suggest that individuals with DS tend to 
more frequently present recurrent episodes of AA, in 
addition to presenting a higher frequency than the 
general population. The most frequently observed 
alopecia was localized on the scalp, which is in accor-
dance with some reports of alopecia in DS (6,26,27). 
In another study at the Medical Genetics Service of 
the IPPMG – UFRJ, we evaluated ten patients with 
AA, mean age 18.6 (SD 7.2) years and observed that 
all patients had one or more lesion in the scalp, two 
patients had lesions at other locations (eyelashes and 
eyebrows), and two patients evolved with total AA. Dif-
ferent reports in the literature demonstrate frequent 
association of alopecia with atopy (7,15,17,18,23). The 
percentile found in our casuistry was approximately 
40.0%, which corroborates this association. It is im-
portant to note that we did not investigate the pos-
sible autoimmune diseases at the time of the study or 
when these individuals presented AA.
A positive family history of AA was observed in 
10.0% to 25.0% of alopecia cases (18,23). However, 
we did not find an affected first-degree relative, sug-
gesting that the occurrence of AA is more related to 
DS than to familial susceptibility in the cases studied.
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Muller and Winkelmann (23) suggest that psycho-
logical factors may be important in the etiopathology 
of AA. The authors observed the precipitation and ac-
centuation of episodes of AA in 12.0% of the popula-
tion studied who had suffered acute emotional stress. 
We suggest that events such as change in school or 
family life might generate psychological stress in in-
dividuals with DS, who have a greater probability of 
presenting emotional and behavioral problems (28), 
a diminished adaptive capacity and difficulties in ap-
proaching new situations (29,30). As we did not com-
pare the social background with age-matched DS 
individuals who did not present with AA, it was not 
possible to assume that environmental, physical, and 
clinical intercurrences may have played a role in the 
genesis of AA in our sample. 
Despite the small sample size, at the Medical Ge-
netics Service of the IPPMG – UFRJ we observed 352 
individuals with DS and only 15 of them presented 
AA, yielding a frequency of approximately 4.2%. This 
finding is in agreement with the literature reporting 
on the frequency of AA in DS from 1.3% to 11.0%.
ConClUSIon
Based on the findings of this study, we suggest 
that the most frequent presentation of AA in DS is 
the localized, non-recurrent form on the scalp, with a 
varied period of duration. We also observed the pres-
ence of changes in school life in more than half of the 
study group. To contribute to the knowledge of this 
issue, we suggest further studies on emotional, im-
munogenetic, and other environmental aspects to 
better understand the etiopathologic mechanisms of 
AA in DS.
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